Tyr Pharma (ATYR) shares remain in focus on Thursday after controversial American investor Martin Shkreli revealed a short ...

The saga of Once Upon a Time in Shaolin, the one-of-a-kind Wu-Tang Clan album that Martin “pharma bro” Shkreli bought for ...

Shkreli's Turing Pharmaceuticals raised the price of an anti-parasitic drug from $13.50 to over $750 overnight, sparking ...

When the Justice Department sold Once Upon a Time in Shaolin it concealed the sale price citing “trade secrets.” Now, after a ...

The price tag behind the government’s sale of Wu-Tang Clan’s Once Upon a Time in Shaolin album has been revealed. According ...

Martin Shkreli, famous for jacking up the price of a generic drug, is touting a weird deal he says he made with Barron Trump. But his reputation for fraud precedes him.

Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban.

"Pharma Bro" Martin Shkreli is facing his day of reckoning Friday, when a judge will hand down a sentence for securities fraud. A federal judge in Brooklyn will weigh two conflicting portrayals of ...

Martin Shkreli’s Ex-Mentor Testifies About His Bad Behavior Steven Richardson, who as chairman of Retrophin fired him as chief executive, was a witness in Mr. Shkreli’s Brooklyn trial on ...

Convicted “Pharma Bro” Martin Shkreli has finally been ousted as boss of the pharmaceutical company he founded, The Post has learned. Activist shareholders booted the group of directors still ...

Martin Shkreli, the “Pharma Bro” who gained notoriety for unapologetically raising drug prices, has been released from federal prison in Pennsylvania and transferred to a halfway house.

Shkreli's father was also present for the reading of the verdict. Former drug company executive Martin Shkreli exits the U.S. District Court in Brooklyn, New York, July 28, 2017.